Prior laxative use common among patients tested for C. diff is

A study published in the American Journal of Infection Control examined the prevalence of prior laxative use among hospitalized adults undergoing Clostridium difficile testing.

Advertisement

Researchers conducted a case-control study of 5,452 C. diff tests from five hospitals in Southeast Michigan. They identified patients who received laxatives in the 24 or 48 hours before testing.

Researchers found that 9.8 percent of patients received laxatives in the 24 hours and 13 percent received laxatives in the 48 hours before testing. The likelihood of receiving laxatives before C. diff was significantly greater for:

• Patients receiving a surgical service rather than a medical service
• Patients residing in an intensive care unit rather than a non-ICU
• Patients whose Elixhauser Comorbidity Score was four or higher

More articles on healthcare quality:
VA hospitals report lower death rates than non-VA facilities, USA Today finds
California fines 5 hospitals $250K+ for patient safety issues
Patients safer, more satisfied when employees like their hospital, study finds

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

When nurses help build the AI, adoption follows: Lessons from 3 health systems

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Amy McCarthy, DNP, RNC-MNN, NE-BC, CENP, Hippocratic AIBeth Reimschissel, PhD, RN, CNL, Memorial HermannAllison Schlinkert, MSN, RN, NPD-BC, Cincinnati Children'sScott Estep, MBOE, BSN, RN, CSSBB, OhioHealth System

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.